Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06699940 · ClinicalTrials.gov registry record
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
A clinical trial, sponsored by Neuronetics.
- Completed
- Registry status
- 7,690
- Enrollment target
NCT06699940 is a clinical trial that has completed, run by Neuronetics. The registered enrollment target is 7,690 participants.
The verdict
NCT06699940 has completed, sponsored by Neuronetics.
- COMPLETED
- Registry status
- 7,690 participants
- Enrollment target
Study Summary
To assess the real-world effectiveness of transcranial magnetic stimulation (TMS) for depression in large adolescent and young adult samples.
Interventions
- DEVICE Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,690 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2023-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06699940
The ClinicalTrials.gov registry entry for NCT06699940 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,690 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.
NCT06699940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06699940 about?
NCT06699940 is a clinical study titled "A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents". To assess the real-world effectiveness of transcranial magnetic stimulation (TMS) for depression in large adolescent and young adult samples.
What is the current status of trial NCT06699940?
This trial is currently completed. The enrollment target is 7,690 participants. The study started on 2023-05-01. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT06699940?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06699940?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.